Pharmacy Market BUZZ

Market News, Products, Services, and Trends

DDWatch February 2023: Missing Opioids, Patient Harm and Hospital Standards


ddwatch.JPG


ST. LOUIS (February 17, 2023) – The newest issue of Drug Diversion Watch (DDWatch) was released this week, featuring the latest information about drug diversion across the U.S. in one location. 

Initially established by ANiGENT as a watchdog tool, the free newsletter has since become one of the fastest-growing news sources shared in the industry. The newsletter is now requested by hospital administrators, pharmacy directors, and other healthcare workers involved in drug diversion prevention.

Here are some of the headlines reported on the latest issue of DDWatch:

     - Thousands of fentanyl doses reported missing in a Missouri hospital

     - Drug diversion arrests increased by 40% in Pennsylvania

     - The slow process of drug diversion investigations can delay suspension and contribute to potential harm

     - The Joint Commission standards on medication management

To read the rest of this month’s DDWatch, click here. To subscribe and receive the newsletter in your inbox every month, click here.



About DDWatch

Drug Diversion Watch (DDWatch) is a free news resource that tracks coverage of medication theft occurring in facilities across the United States. It is disseminated to thousands of hospital administrators, pharmacy directors, and other healthcare workers around the country. 


Created by ANiGENT, a Midwest drug diversion prevention solutions provider, DDWatch also features interviews with subject matter experts in several industries. Participation in these interviews do not represent an endorsement of ANiGENT or any of its products. To learn more about DDWatch and ANiGENT, or to subscribe, please visit ANiGENT.com/DD-Watch


Today's Posts
Subscribe